微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.32% | 13.19% | -57.64% | 7/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 12.56% | 39.71% | -15.93% | 13/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 14.94% | 53.7% | 106.07% | 6/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 7.25% | 19.64% | 54.26% | 16/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 4.7% | 4.68% | -47.72% | 12/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 8.99% | -25.52% | -7.51% | 27/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 9.72% | -50.33% | 60.4% | 20/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 6.06% | 85.89% | 34.97% | 21/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 4.49% | 59.22% | -62.8% | 16/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.07% | 124.35% | -38.32% | 21/69 | 6.65% | 片仔癀 | 23.54% | 行业排名> |
| 2022-09-30 | 19.57% | 272.76% | 500.31% | 2/69 | 5.16% | *ST吉药 | 72.63% | 行业排名> |
| 2022-06-30 | 3.26% | -3.26% | 15.6% | 38/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.82% | 39.6% | -47.58% | 28/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 5.38% | 28.1% | 2.48% | 44/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.25% | 0.57% | 55.79% | 46/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.37% | 8.01% | 66.83% | 46/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.02% | 16.76% | -51.9% | 40/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 4.2% | -8.5% | -19.54% | 44/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 5.22% | -19.32% | 67.31% | 41/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 3.12% | -16.13% | 80.35% | 39/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.73% | -22.77% | -62.31% | 37/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 4.59% | -23.63% | -29.06% | 46/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 6.47% | 7.83% | 73.92% | 38/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 3.72% | -9.49% | 66.07% | 42/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.24% | -4.68% | -62.73% | 40/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 6.01% | 16.02% | 0.17% | 45/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 6% | -23.18% | 45.99% | 43/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 4.11% | -9.27% | 74.89% | 38/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.35% | 23.68% | -54.63% | 36/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 5.18% | -25.04% | -33.67% | 50/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 7.81% | 25.36% | 72.41% | 36/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 4.53% | 27.61% | 138.42% | 37/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.9% | 7.34% | -72.5% | 38/69 | 2.62% | 济川药业 | 14.64% | 行业排名> |
| 2016-12-31 | 6.91% | -26.57% | 10.91% | 47/69 | 10.02% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 6.23% | -27.73% | 75.49% | 36/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 3.55% | -38.69% | 100.57% | 46/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 1.77% | -30.04% | -81.19% | 41/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 9.41% | -46.96% | 9.16% | 39/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 8.62% | -43.36% | 48.88% | 30/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 5.79% | -43.12% | 128.85% | 29/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2.53% | 2% | -85.74% | 33/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |